SHYFT Analytics, a Medidata Solutions company, and PAREXEL International, have entered into a strategic partnership that establishes SHYFT’s technology as an integral part of PAREXEL’s foundation for Real-World Evidence (RWE) generation and outcomes research for biopharmaceutical and medical device clients.   The collaboration combines PAREXEL’s scientific and clinical services with SHYFT’s suite of RWE products to help provide insights and outcomes from patient-level data more efficiently to ...